Skip to main content

News

Press release year list 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
03/22/2023
Marinus Pharmaceuticals Receives FDA Orphan Drug Designation for Ganaxolone in the Treatment of Lennox-Gastaut Syndrome
DownloadPDF format download (opens in new window)
03/07/2023
Marinus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2022 Financial Results
DownloadPDF format download (opens in new window)
03/06/2023
Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
DownloadPDF format download (opens in new window)
02/13/2023
Marinus Pharmaceuticals to Provide Business Update and Report Fourth Quarter 2022 Financial Results on March 7, 2023
DownloadPDF format download (opens in new window)
02/10/2023
Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
DownloadPDF format download (opens in new window)
02/07/2023
Marinus Pharmaceuticals to Present at Upcoming Investor Conferences
DownloadPDF format download (opens in new window)
01/30/2023
Marinus Pharmaceuticals Appoints Christine Silverstein to its Board of Directors
DownloadPDF format download (opens in new window)
01/09/2023
Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
DownloadPDF format download (opens in new window)
01/05/2023
Marinus Pharmaceuticals Reports Preliminary Fourth Quarter and Full Year 2022 ZTALMY® Net Product Revenue and Provides Business Update
DownloadPDF format download (opens in new window)